Show simple item record

Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience

dc.contributor.authorSahu, Kamal Kant
dc.contributor.authorSiddiqui, Ahmad Daniyal
dc.contributor.authorCerny, Jan
dc.date2022-08-11T08:08:11.000
dc.date.accessioned2022-08-23T15:45:52Z
dc.date.available2022-08-23T15:45:52Z
dc.date.issued2020-07-01
dc.date.submitted2020-08-03
dc.identifier.citation<p>Sahu KK, Siddiqui AD, Cerny J. Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11. PMID: 32445595; PMCID: PMC7283851. <a href="https://doi.org/10.1111/bjh.16880">Link to article on publisher's site</a></p>
dc.identifier.issn0007-1048 (Linking)
dc.identifier.doi10.1111/bjh.16880
dc.identifier.pmid32445595
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27628
dc.description.abstractCoronavirus disease 19 (COVID‐19) has posed unparalleled challenges for health care communities, the general population, and in particular, for patients suffering from various comorbidities. Patients with hematological disorders, both benign and malignant need special attention during this crisis time to ensure uninterrupted delivery of optimal care (Sahu & Siddiqui, 2020).
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32445595&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283851/
dc.subjectanemia
dc.subjectcoronavirus
dc.subjectCOVID-19
dc.subjectpandemic
dc.subjectsickle cell anemia
dc.subjectviruses
dc.subjectCongenital, Hereditary, and Neonatal Diseases and Abnormalities
dc.subjectHealth Services Administration
dc.subjectHemic and Lymphatic Diseases
dc.subjectInfectious Disease
dc.subjectVirus Diseases
dc.titleManaging sickle cell patients with COVID-19 infection: the need to pool our collective experience
dc.typeJournal Article
dc.source.journaltitleBritish journal of haematology
dc.source.volume190
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/79
dc.identifier.contextkey18774269
html.description.abstract<p>Coronavirus disease 19 (COVID‐19) has posed unparalleled challenges for health care communities, the general population, and in particular, for patients suffering from various comorbidities. Patients with hematological disorders, both benign and malignant need special attention during this crisis time to ensure uninterrupted delivery of optimal care (Sahu & Siddiqui, 2020).</p>
dc.identifier.submissionpathcovid19/79
dc.contributor.departmentDivision of Hematology and Oncology, Department of Medicine
dc.source.pagese86-e89


This item appears in the following Collection(s)

Show simple item record